...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.
【24h】

Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.

机译:在人骨髓的红细胞分化过程中,IFN诱导的p53-target基因TRIM22的表达下调。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The interferon inducible protein TRIM22 has been identified as a p53 target gene, with possible involvement in proliferation and differentiation of leukaemia cells. Here, the expression levels of TRIM22 during haematopoietic differentiation are characterised. Expression of TRIM22 correlates inversely to differentiation, as TRIM22 is highly expressed in CD34(+) human bone marrow progenitor cells, but declines in mature populations. The erythroid lineage appears as a special case, as TRIM22 expression shows an extreme decrease during late erythroid maturation and is completely undetectable in nucleated erythroid populations in contrast to other lineages. In conclusion, our data could suggest lineage-specific roles for TRIM22 during haematopoietic differentiation.
机译:干扰素诱导蛋白TRIM22已被鉴定为p53靶基因,可能参与白血病细胞的增殖和分化。 在这里,造血分化过程中TRIM22的表达水平是特征的。 TRIM22的表达与分化相关,因为TRIM22在CD34(+)人骨髓祖细胞中高度表达,但在成熟的种群中下降。 红细胞谱系作为一种特殊情况,因为TRIM22表达在红斑成熟后期表现出极大的降低,并且与其他谱系相比,在核红细胞种群中完全无法检测到。 总之,我们的数据可以表明造血分化过程中TRIM22的谱系特异性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号